Harmony Pharma (HRMY) - P/E multiplikatori

Harmony Pharma - HRMY emitenti grafik logotipi

Harmony Biosciences noyob markaziy nerv tizimi patologiyalari uchun ilg'or terapiyalarni yaratish va yangi molekulalarni ishlab chiqishga e'tibor qaratadi. Kompaniyaning oylik P/E dinamikasi bozor kutganlarini aks ettiradi va qiymat 11.20 darajasida barqarorlashgan. Xatarlarni kamaytirish asosiy dori vositasining kengaytirilgan qo'llanilishi orqali amalga oshirilmoqda, taqsimot va sinov samaradorligi esa tashqi pudratchilar jalb qilinishi orqali qo'llab-quvvatlanmoqda.

Harmony Biosciences Holdings, Inc. (HRMY) - Narxning foydaga nisbati 04.07.2022dan 16.11.2026gacha

Harmony Biosciences kompaniyasining tahliliy kesimlari

Kompaniyaning umumiy tahlili:HRMY (Harmony Pharma)
harmonybiosciences.com original mahsuloti

Harmony Biosciences noyob nevrologik buzilishlar, jumladan, narkolepsiya davolash uchun dori vositalarini tijoratlashtirishga ixtisoslashgan. Bozor qiymatining sof foydaga nisbati kapitalizatsiyaning qoplash muddatini raqamlashtiradi, bu esa P/E baholash tendentsiyasiga tartibga soluvchi o'zgarishlar va biofarmatsevtika sektoridagi tez-tez uchraydigan tebranishlar fonida investor kelajakdagi daromadlar o'sishi uchun haddan tashqari ko'p to'layotganini aniqlash imkonini beradi.

Raqobatdosh kompaniyalar

Narxning foydaga nisbati BIIB|P/E multiplikatori NBIX|Regencell (RGC) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati axsome.com AXSM|P/E multiplikatori ACADIA Pharmaceuticals ACAD|XENE - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Viking Therapeutics Inc VKTX|Supernus Pharma (SUPN) - Narxning foydaga nisbati|CPRX (Catalyst Pharmaceuticals) - Narxning foydaga nisbati|DNLI (denalitherapeutics.com) - P/E multiplikatori|Narxning foydaga nisbati BHVN|Narx-foyda koeffitsiyenti AMLX (Amylyx Pharmaceuticals, Inc.)|Bozor narxining sof foydaga nisbati TRVI|Narxning foydaga nisbati Praxis Precision Medicines, Inc. PRAX|Anavex Corp - Narxning foydaga nisbati|CBLL: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati PRTA (prothena.com)|Alector, Inc. (ALEC) - Narxning foydaga nisbati|Narx-foyda multiplikatori ANNX|Narxning foydaga nisbati Omeros Corp.|Neurogene Therapeutics (NGNE) - Biznesning o‘zini qoplash muddati|P/E multiplikatori ACIU|VYGR (Voyager Therapeutics) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori NMRA (neumoratx.com)|SCLX: Narx-foyda multiplikatori|TVGN - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Alpha Cognition Inc.|CGTX: P/E multiplikatori|inhibikase.com (IKT) - P/E multiplikatori|Narxning foydaga nisbati Cassava Sciences Inc|ASRT - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati Coya (COYA)|P/E multiplikatori VistaGen Therapeutics Inc (VTGN)|Ovid Therapeutics Inc. - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Acumen Pharmaceuticals (ABOS)|CervoMed Corporation - P/E multiplikatori|Biznesning o‘zini qoplash muddati alteritytherapeutics.com ATHE|CLNN: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati PepGen Corp (PEPG)|Narxning foydaga nisbati Jupiter Neurosciences, Inc.|RLMD: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ANVS|Narx-foyda koeffitsiyenti Grace Tx GRCE|Narxning foydaga nisbati Firefly Neuroscience, Inc AIFF|KLTO: Narx-foyda multiplikatori|NRSN - Narxning foydaga nisbati|RVPH: Narxning foydaga nisbati|MTVA (MetaVia Inc.) - Narx-foyda koeffitsiyenti|NeurAxis Inc. (NRXS) - P/E multiplikatori|Narxning foydaga nisbati Helius Medical|Passage Bio, Inc. - Kapitalizatsiyaning sof foydaga nisbati|Narx-foyda koeffitsiyenti NEUP (Neuphoria)|NERV - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ATHA (athira.com)|P/E multiplikatori Addex Therapeutics Ltd ADXN|Alzamend Neuro, Inc. - P/E multiplikatori|CYCN - P/E multiplikatori|PTIX (Protagenic Therapeutics, Inc.) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Pasithea (KTTA)|Narxning foydaga nisbati Cortigent|Kapitalizatsiyaning foydaga nisbati Avenue Therapeutics Inc. ATXI|Narxning foydaga nisbati brainstorm-cell.com (BCLI)|Narx-foyda koeffitsiyenti Cara Therapeutics, Inc CARA|P/E multiplikatori CHRO (chromocell.com)|Kompaniya qiymatining sof foydaga nisbati ELYM|Intra-Cellular Therapies Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Longboard Pharmaceuticals Inc|Marinus (MRNS) - Narxning foydaga nisbati|NKGN - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati NeuroBo Pharmaceuticals|SAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori SNPX|Trevena Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical, Inc. - Narxning foydaga nisbati|Cerevel Therapeutics - P/E multiplikatori